Optimizing for faster quality control in cell therapies: leveraging rapid detection methods
This infographic summarizes three separate Case Studies that explore the optimization and effective application of novel rapid detection methods in cell therapy QC, including a specific example in the CAR-T cell therapy area. Insights into evolving regulatory attitudes towards rapid, nucleic acid-based mycoplasma and sterility testing tools are also shared.
Institutions
- Vifor Pharma (United States) (US)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2025-09-08
- DOI
- https://doi.org/10.18609/cgti.2025.097
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00